T
Tibetha S. Santucci
Researcher at Allegheny General Hospital
Publications - 12
Citations - 1082
Tibetha S. Santucci is an academic researcher from Allegheny General Hospital. The author has contributed to research in topics: Laparoscopic surgery & Lung cancer. The author has an hindex of 10, co-authored 12 publications receiving 1031 citations. Previous affiliations of Tibetha S. Santucci include Allegheny College & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Segmental resection spares pulmonary function in patients with stage I lung cancer
Robert J. Keenan,Rodney J. Landreneau,Richard H. Maley,Deepak Singh,Robin S. Macherey,Susan Bartley,Tibetha S. Santucci +6 more
TL;DR: For patients with stage I non-small cell lung cancer, segmental resection offers preservation of pulmonary function compared with lobectomy and does not compromise survival.
Journal ArticleDOI
Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Helen Han,Jan F. Silverman,Tibetha S. Santucci,Robin S. Macherey,Thomas A. d’Amato,Ming Y. Tung,Robert J. Weyant,Rodney J. Landreneau +7 more
TL;DR: High VEGF expression, tumor size, and angiolymphatic invasion emerged as three independent factors predicting worsening prognosis using multivariate analysis.
Journal ArticleDOI
Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer.
Ricardo S. Santos,Athanasios Colonias,David S. Parda,Mark Trombetta,Richard H. Maley,Robin S. Macherey,Susan Bartley,Tibetha S. Santucci,Robert J. Keenan,Rodney J. Landreneau +9 more
TL;DR: This safe, pulmonary function-preserving and practical intraoperative brachytherapy method should be considered when SR is used as a "compromise" therapy in high-risk Stage I NSCLC patients.
Journal ArticleDOI
A comparative study of buttressed versus nonbuttressed staple line in pulmonary resections.
TL;DR: With greater number of patients studied, it is likely that the cost of bovine pericardium would be justified by shorter air leak duration and hospitalization, and the trend toward shortened air leak time and tube removal time was apparent in the buttressed group.
Journal ArticleDOI
Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Helen Han,Rodney J. Landreneau,Tibetha S. Santucci,Ming Y. Tung,Robin S. Macherey,Stanley E. Shackney,Charles D. Sturgis,Stephen S. Raab,Jan F. Silverman +8 more
TL;DR: In this article, the authors evaluated a number of molecular markers that may aid in predicting prognosis in stage I non-small-cell lung cancer after surgical resection, and found that overexpression of p53 and HER-2/ neu, presence of angiolymphatic invasion and tumor size > 3.0 cm were independent factors predicting poor survival.